Bio-Techne
Update in progressTECH (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Bio-Techne Corporation and its subsidiaries develop, manufacture, and sell life science reagents, instruments, and services for research, diagnostics, and bioprocessing worldwide. It operates in two segments: Protein Sciences, providing proteins, antibodies, cytokines, growth factors, small molecules, sera, and proteomics tools; and Diagnostics and Spatial Biology, offering diagnostic kits, controls, exosome assays, in situ hybridization, genetic/oncology assays, and related instruments. Incorporated 1976, formerly Techne, based in Minneapolis.
Company score
- Sentiment
- 0.31
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.12
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.26
- Governance
- 0.11
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.06
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.19
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMr. Kim Kelderman
- Founded1976
- Employees3,000
- Websitewww.bio-techne.com
Identifiers
- ISINUS09073M1045
- FIGIBBG000C15114
- LEI54930073RLKQ51TILZ35
- CUSIP09073M104
- CIK0000842023